As the world’s leading chemical company, BASF believes that it can play a crucial role in meeting the needs of a growing world population – by conserving resources, by ensuring healthy food and nutrition, and by improving people’s quality of life. We have summarized what we do as a company in our purpose: We create chemistry for a sustainable future.
Innovations are the basis of BASF’s profitable growth. By continuously developing new products, innovative processes and solutions for customers, we are extending our leading position in the chemical industry.
With about 109,000 employees and close to 385 production sites worldwide we serve customers and partners in almost all countries of the world.
BASF, the world’s first industrial company to publish a comprehensive carbon footprint, offers a variety of solutions to protect the climate, including products for energy efficient vehicles and buildings, and products to make wind and solar energy more economic.
Our products and solutions for the automotive industry – ranging from catalysts and fuel additives to plastics and coatings – improve comfort, enhance performance, reduce fuel consumption, ensu
re more safety and lower emissions. We have helped car manufacturers Hyundai and Daimler-Chrysler to develop concept cars which demonstrate new concepts in energy efficiency, temperature management and lightweight design.
As the leading raw material supplier to the construction industry, BASF has built show houses around the world to demonstrate how, with our energy efficient, economically and environmentally sound solutions, contractors and home owners can protect the climate and save costs.
The world’s growing population needs healthy and adequate nutrition and access to clean drinking water. BASF’s crop protection products increase quality and secure crop yields. Research in plant biotechnology concentrates on plants for greater efficiency in agriculture, healthier nutrition and for use as renewable raw materials. We are convinced that plant biotechnology is a key technology for the 21st century, but there is still a lack of acceptance for this technology from the majority of consumers, farmers and politicians in many parts of Europe. BASF also offers solutions which save water or improve its quality.
The Science in Environment Category and Award is supported by BASF
European Science Foundation (ESF)
The establishment of the European Science Foundation (ESF) in Strasbourg in 1974 was one of the earliest milestones on the road to achieving real cooperation in European research. The ESF began life with a membership of 42 academies and research councils in 15 countries; in 2012 it counts 72 Member Organisations (MOs), including research funding organisations, research performing organisations and academies in 30 countries.
As an independent, non-governmental organisation dedicated to pan-European scientific networking and collaboration, the ESF has had a key role to play in mediating between a multitude of heterogeneous research cultures and agencies. The ESF hosts an array of instruments to accommodate various types and levels of international collaboration, within Europe and beyond. The ESF’s unique characteristic in this area is its responsiveness to the scientific community, in contrast with the more targeted approaches taken by the European Commission. Many of the instruments operated by the ESF, e.g. Exploratory Workshops, EUROCORES (European Collaborative Research scheme), Research Networking Programmes (RNPs) and ESF Research Conferences, are designed to respond to needs articulated by the research community. In recent years, the ESF’s profile has shifted from being mainly a facilitator of collaborative research and networking to also providing a platform for Member Organisations to develop joint strategic operations and synergy among themselves. The ESF provides high level and high quality foresight and advice on science, research infrastructure and science policy issues. Specific activities include Forward Looks, Member Organisation Fora, Exploratory Workshops and Science Policy Briefings.
By coordinating the strategic agendas of its members in this way, greater leverage over a much larger European budget and agenda is achieved. In other words, the ESF maximises the impact of its support to the research community by combining bottom-up and top-down approaches to scientific cooperation.
In 38 years of achievement, ESF has helped to change minds throughout Europe and beyond: it has demonstrated the value of networks and partnerships and the synergies that emerge from interdisciplinary and cross-border collaboration. Cooperation of a kind that was once rare is now routine.
The Science in New Media Category and Award is being supported by the European Science Foundation
Our Purpose: The Promise of Better Healthcare
At Janssen Research & Development, A Division of Janssen Pharmaceutica N.V.,
we start each day focused on the promise that better healthcare can bring to
patients around the world.
By leveraging our world-class discovery and development expertise, we bring innovative, effective treatments for infectious diseases & vaccines, cardiovascular & metabolic diseases , immunology, oncology and central nervous system disorders to ease patients’ suffering and to significantly improve their health and overall quality of life.
While some medical conditions are very treatable, and even curable, for many patients, there are conditions where treatments are sub-optimal or where there are a limited number of therapeutic options available to afford them relief. Yet, the wealth of information generated by modern medicine and the convergence of other fields underpinning science-based healthcare solutions is changing the face of science and medicine at an unprecedented pace, while opening a world of once-unforeseen possibilities. Within our labs, scientists are harnessing these advances and are breaking new ground in the development of tomorrow’s medicines, with the aim of bringing patients greater relief through new treatment options.
Many of the compounds we are developing have the potential to be first-in-class or best-in-class in their therapeutic category. As a result, our pipeline is strong and robust in all stages of development with technologically differentiated and therapeutically diverse compounds.